Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

Clinical trial NCT05034497 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05034497
Sponsor: Plus Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leptomeningeal Metastasis

Start date: 2021-12-06
Primary completion: 2025-12-21
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.